Bruker Corporation (NASDAQ:BRKR) Receives Consensus Rating of "Hold" from Brokerages

Key Points

• Bruker Corporation has received a consensus rating of "Hold" from eleven analyst coverages, with recommendations split between buy (5), hold (5), and sell (1).
• The company's recent quarterly earnings report indicated an EPS of $0.32, missing the consensus estimate, alongside a revenue of $797.40 million, which was below analysts' expectations.
• Bruker declared a quarterly dividend of $0.05 per share, translating to an annual yield of 0.5%, with a payout ratio of 38.46%.

Shares of Bruker Corporation (NASDAQ:BRKR - Get Free Report) have been given a consensus rating of "Hold" by the eleven analysts that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and five have given a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $51.00.

Several analysts have recently commented on BRKR shares. Bank of America lowered their price target on Bruker from $61.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. Stifel Nicolaus set a $40.00 price target on shares of Bruker and gave the stock a "hold" rating in a report on Tuesday, August 5th. Weiss Ratings reiterated a "sell (d+)" rating on shares of Bruker in a report on Wednesday, October 8th. Jefferies Financial Group set a $60.00 price target on Bruker and gave the stock a "buy" rating in a research note on Monday, August 4th. Finally, Wells Fargo & Company decreased their target price on shares of Bruker from $60.00 to $50.00 and set an "overweight" rating for the company in a research report on Tuesday, August 5th.

Bruker Trading Up 2.0%

Shares of NASDAQ BRKR opened at $39.71 on Friday. The company has a quick ratio of 0.70, a current ratio of 1.61 and a debt-to-equity ratio of 1.31. Bruker has a 12 month low of $28.53 and a 12 month high of $64.64. The company has a market cap of $6.02 billion, a price-to-earnings ratio of 76.37, a P/E/G ratio of 5.48 and a beta of 1.20. The business has a fifty day simple moving average of $33.96 and a 200-day simple moving average of $37.02.

Bruker (NASDAQ:BRKR - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The medical research company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.33 by ($0.01). Bruker had a return on equity of 17.89% and a net margin of 2.31%.The company had revenue of $797.40 million for the quarter, compared to analyst estimates of $811.17 million. During the same quarter in the previous year, the firm posted $0.52 EPS. Bruker's quarterly revenue was down .4% on a year-over-year basis. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. Sell-side analysts predict that Bruker will post 2.69 EPS for the current year.

Bruker Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 3rd. Stockholders of record on Tuesday, September 23rd were paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.5%. The ex-dividend date was Tuesday, September 23rd. Bruker's dividend payout ratio is 38.46%.

Insider Buying and Selling at Bruker

In related news, Director Cynthia M. Friend sold 3,535 shares of the business's stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $32.25, for a total value of $114,003.75. Following the completion of the sale, the director directly owned 18,016 shares in the company, valued at approximately $581,016. The trade was a 16.40% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 27.30% of the company's stock.

Hedge Funds Weigh In On Bruker

A number of institutional investors have recently modified their holdings of the company. Nisa Investment Advisors LLC lifted its stake in shares of Bruker by 727.9% in the third quarter. Nisa Investment Advisors LLC now owns 5,100 shares of the medical research company's stock worth $166,000 after buying an additional 4,484 shares during the last quarter. SG Americas Securities LLC raised its holdings in Bruker by 199.8% in the 3rd quarter. SG Americas Securities LLC now owns 42,293 shares of the medical research company's stock worth $1,374,000 after acquiring an additional 28,184 shares during the period. Spire Wealth Management lifted its position in Bruker by 85.3% during the 3rd quarter. Spire Wealth Management now owns 1,445 shares of the medical research company's stock worth $47,000 after acquiring an additional 665 shares during the last quarter. Park Avenue Securities LLC bought a new stake in Bruker during the third quarter valued at about $238,000. Finally, Sivik Global Healthcare LLC acquired a new stake in shares of Bruker in the third quarter valued at about $1,949,000. Institutional investors own 79.52% of the company's stock.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.